Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · IEX Real-Time Price · USD

3.920

+0.120 (3.16%)

At close: Jul 26, 2024, 3:32 PM

3.560

-0.360 (-9.18%)

After-hours: Jul 26, 2024, 7:03 PM EDT

Phio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Net Income	-9.38	-10.83	-11.48	-13.29	-8.79	-8.91	Upgrade
Depreciation & Amortization	0.17	0.18	0.19	0.19	0.07	0.07	Upgrade
Loss (Gain) From Sale of Assets	0	-	-	-	-	-	Upgrade
Asset Writedown & Restructuring Costs	0.13	0.13	-	-	-	-	Upgrade
Stock-Based Compensation	0.22	0.3	0.41	0.48	0.14	0.3	Upgrade
Other Operating Activities	-	-	-	-0.23	0.11	0.11	Upgrade
Change in Accounts Payable	-0.58	-0.12	0.5	-0.45	-0.08	0.26	Upgrade
Change in Other Net Operating Assets	-0.62	-0.41	-1.75	1.44	-0.25	-0.47	Upgrade
Operating Cash Flow	-10.05	-10.75	-12.13	-11.86	-8.8	-8.65	Upgrade
Capital Expenditures	-0.01	-0.01	-0.12	-0.05	-0.02	-0.07	Upgrade
Investing Cash Flow	-0.01	-0.01	-0.12	-0.05	-0.02	-0.07	Upgrade
Long-Term Debt Issued	-	-	-	-	0.23	-	Upgrade
Long-Term Debt Repaid	-	-	-	-	-0.03	-0.01	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	0.2	-0.01	Upgrade
Issuance of Common Stock	7.45	7.45	-	21.72	15.94	0.78	Upgrade
Repurchase of Common Stock	-0.01	-0.04	-0.03	-0	-0.02	-0	Upgrade
Financing Cash Flow	7.45	7.41	-0.03	21.72	16.13	0.77	Upgrade
Net Cash Flow	-2.61	-3.34	-12.28	9.81	7.31	-7.95	Upgrade
Free Cash Flow	-10.06	-10.75	-12.25	-11.91	-8.82	-8.72	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-41509.52%	Upgrade
Free Cash Flow Per Share	-30.75	-46.45	-97.00	-100.24	-207.68	-	Upgrade
Cash Interest Paid	-	-	-	-	0.01	0.01	Upgrade
Levered Free Cash Flow	-6.39	-6.53	-7.81	-6.71	-5.55	-5.39	Upgrade
Unlevered Free Cash Flow	-6.39	-6.53	-7.81	-6.71	-5.55	-5.39	Upgrade
Change in Net Working Capital	1.01	0.37	1.13	-1.11	0.25	0.07	Upgrade

Source: S&P Capital IQ. Standard template.